| Authors: |
Pearson AD; The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, London, UK. Electronic address: andy1pearson@btinternet.com., Herold R; Product Development Scientific Support Department, European Medicines Agency, Canary Wharf, London, UK., Rousseau R; Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Copland C; Centre for English Language Teaching, University of York, UK., Bradley-Garelik B; Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA., Binner D; Create for Chloe and UK representative for aPODD, UK., Capdeville R; Novartis Pharma AG, Basel CH-4002, Switzerland., Caron H; Hoffman-La Roche, Basel, Switzerland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands., Carleer J; Belgian Federal Agency for Medicines and Health Products, Brussels, Belgium., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Geoerger B; Department of Pediatric and Adolescent Oncology, Gustave Roussy, France., Kearns P; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Marshall LV; The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, London, UK; Children and Young People's Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK., Pfister SM; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and Heidelberg University Hospital, Heidelberg 69120, Germany., Schleiermacher G; U830 INSERM, Recherche Translationelle en Oncologie Pédiatrique (RTOP) and Department of Pediatric Oncology, Institut Curie, Paris, France., Skolnik J; TetraLogic Pharmaceuticals, Malvern, PA 19355, USA., Spadoni C; aPODD Foundation, London, UK., Sterba J; Department of Paediatric Oncology, Faculty of Medicine, University Hospital Brno and Masaryk University, Brno, Czech Republic; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, ICRC Brno, Brno, Czech Republic., van den Berg H; Product Development Scientific Support Department, European Medicines Agency, Canary Wharf, London, UK., Uttenreuther-Fischer M; Boehringer Ingelheim, Germany., Witt O; Clinical Cooperation Unit Pediatric Oncology (G340), German Cancer Research Center (DKFZ), Heidelberg, Germany., Norga K; Paediatric Haematology/Oncology Unit, Antwerp University Hospital, Antwerp University, Belgium., Vassal G; Department of Clinical Research, Institut Gustave Roussy, Paris-Sud University, Paris, France. |
